MgCl2/Et3N Base System as a New Catalyst for the Synthesis of α-Hydroxy Phosphonate
[14] Eymery, F.; Lorga, B.; Savignac, P. Tetrahedron 1999, 55, 2671.
[15] Firouzabadi, H.; Iranpoor, N.; Sobhani, S.; Amoozgar, Z. Synthesis
2004, 1771.
[16] Evans, D. A.; Hurst, K. M.; Takacs, J. M. J. Am. Chem. Soc.1978,
100, 3467.
[17] Texier-Boullet, F.; Foucaud, A. Synthesis 1982, 916.
[18] Texier-Boullet, F.; Lequitte, M. Tetrahedron Lett. 1986, 27, 3515.
[19] Heydari, A.; Arefi, A.; Khaksar, S.; Tajbakhsh, M. Catal. Commun.
2006, 7, 98.
ence of MgCl2/Et3N base system. The advantages of this
procedure are operational simplicity, wide substrate
scope, and high yields. In many cases, the products
crystallized directly from the reaction mixture in high
purity. We believe that this method presents a practical
alternative to existing procedures for the synthesis of
α-hydroxyphosphonates.
[20] Saito, B.; Egami, H.; Katsuki, T. J. Am. Chem. Soc. 2007, 129, 1978.
[21] Dodda, R.; Zhao, C. G. Org. Lett. 2006, 8, 4911.
[22] Yokomatsu, T.; Yamagishi, T.; Shibuya, S. Tetrahedron: Asymmetry
1993, 4, 1779.
[23] Tajbakhsh, M.; Heydari, A.; Khalilzadeh, M. A.; Lakouraj, M. M.;
Zamenian, B.; Khaksar, S. Synlett 2007, 2347.
Acknowledgment
Financial support of this work from the Research
Council of the University of Mazandaran is gratefully
acknowledged.
[24] Chen, W.; Hui, Y.; Zhou, X.; Jiang, J.; Cai, Y.; Liu, X.; Lin, L.;
Feng, X. Tetrahedron Lett. 2010, 51, 4175.
[25] Zhou, X.; Liu, Y.; Chang, L.; Zhao, J.; Shang, D.; Liu, X.; Lin, L.;
Feng, X. Adv. Synth. Catal. 2009, 351, 2567.
[26] Cai, Z. H.; Du, G. F.; He, L.; Gu, C. Z.; Dai, B. Synthesis 2011, 2073.
[27] Kharasch, M. S.; Mosher, R. A.; Bengelsdorf, I. S. J. Org. Chem.
1960, 25, 1000.
[28] Zhang, M.; Zhang, A.-Q.; Huang, Y.-X. Chin. J. Org. Chem. 2005,
25, 1133.
[29] (a) Rathke, M. W.; Cowan, P. J. J. Org. Chem. 1985, 50, 2622; (b)
Rathke, M. W.; Nowak, M. A. Synth. Commun. 1985, 15, 1039.
[30] (a) Hofsløkken, N. U.; Skattebøl, L. Acta Chem. Scand. 1999, 53,
258; (b) Hansen, T. V.; Skattebøl, L. Org. Synth. 2005, 82, 64.
[31] Anwar, H. F.; Skattebøl, L.; Hansen, T. V. Tetrahedron 2007, 63,
9997.
References
[1] Kim, D. Y.; Wiemer, D. F. Tetrahedron Lett. 2003, 44, 2803.
[2] Neyts, J.; De Clercq, E. Antimicrob. Agents Chemother. 1997, 41,
2754.
[3] Fleisch, H. Endocr. Rev. 1998, 19, 80.
[4] Snoeck, R.; Holy, A.; Dewolf-Peeters, C.; Van Den Oord, J.; De
Clercq, E.; Andrei, G. Antimicrob. Agents Chemother. 2002, 46,
3356.
[5] Lee, M. V.; Fong, E. M.; Singer, F. R.; Guenett, R. S. Cancer Res.
2001, 61, 2602.
[6] Kafarski, P.; Lejczak, B. J. Mol. Catal. B: Enzym. 2004, 29, 99.
[7] Patel, D. V.; Rielly-Gauvin, K.; Ryono, D. E.; Free, C. A.; Rogers, W.
L.; Smith, S. A.; DeForrest, J. M.; Oehl, R. S.; Petrillo, E. W. Jr. J.
Med. Chem. 1995, 38, 4557.
[8] Stowasser, B.; Budt, K. H.; Jian-Qi, L.; Peyman, A.; Ruppert, D. Tet-
rahedron Lett. 1992, 33, 6625.
[32] Tamai, S.; Ushirogochi, H.; Sano, S.; Nogao, Y. Chem. Lett. 1995,
295.
[33] (a) Asghari, S.; Tajbakhsh, M.; Jafarzadeh, B. K.; Khaksar, S. Chin.
Chem. Lett. 2011, 22, 127; (b) Tajbakhsh, M.; Khaksar, S.; Zamenian,
B.; Jahani, F. Synthesis 2010, 3315; (c) Jahani, F.; Tajbakhsh, M.;
Golchoubian, H.; Khaksar, S. Tetrahedron Lett. 2011, 52, 1260; (d)
Vahdat, S. M.; Baharfar, R.; Tajbakhsh, M.; Heydari, A.; Baghbanian,
S. M.; Khaksar, S. Tetrahedron Lett. 2008, 49, 6501.
[9] Zheng, X.; Nair, V. Tetrahedron 1999, 55, 11803.
[10] Patel, D. V.; Rielly-Gauvin, K.; Ryono, D. E. Tetrahedron Lett. 1990,
31, 5591.
[11] Fields, S. C. Tetrahedron 1999, 55, 12237.
[12] Kaboudin, B. Tetrahedron Lett. 2003, 44, 1051.
[13] Nesterov, V. V.; Kolodiazhnyi, O. I. Tetrahedron 2007, 63, 6720.
(Pan, B.; Qin, X.)
Chin. J. Chem. 2012, 30, 827—829
© 2012 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
829